Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment
NCT06323837
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Stimulant Use Disorder
Interventions
DRUG:
Mirtazapine
DRUG:
Placebo
Sponsor
Washington State University